Journal articles on the topic 'Targeted antigen delivery'
Create a spot-on reference in APA, MLA, Chicago, Harvard, and other styles
Consult the top 50 journal articles for your research on the topic 'Targeted antigen delivery.'
Next to every source in the list of references, there is an 'Add to bibliography' button. Press on it, and we will generate automatically the bibliographic reference to the chosen work in the citation style you need: APA, MLA, Harvard, Chicago, Vancouver, etc.
You can also download the full text of the academic publication as pdf and read online its abstract whenever available in the metadata.
Browse journal articles on a wide variety of disciplines and organise your bibliography correctly.
Wengerter, Brian C., Joseph A. Katakowski, Jacob M. Rosenberg, Chae Gyu Park, Steven C. Almo, Deborah Palliser, and Matthew Levy. "Aptamer-targeted Antigen Delivery." Molecular Therapy 22, no. 7 (July 2014): 1375–87. http://dx.doi.org/10.1038/mt.2014.51.
Full textBourque, Jessica, and Daniel Hawiger. "Applications of Antibody-Based Antigen Delivery Targeted to Dendritic Cells In Vivo." Antibodies 11, no. 1 (January 25, 2022): 8. http://dx.doi.org/10.3390/antib11010008.
Full textKawasaki, Norihito, Weihsu Chen, Jose Vela, Corwin Nycholat, Igor Maricic, Kumar Vipin, Paul Crocker, Mitchell Kronenberg, and James Paulson. "Efficient lipid antigen presentation to NKT cells by targeting CD169/Siglec-1 on macrophages with its glycan ligand. (100.49)." Journal of Immunology 186, no. 1_Supplement (April 1, 2011): 100.49. http://dx.doi.org/10.4049/jimmunol.186.supp.100.49.
Full textWi, Tae In, Yeongseon Byeon, Ji Eun Won, Jae Myeong Lee, Tae Heung Kang, Jeong-Won Lee, Young Joo Lee, Anil K. Sood, Hee Dong Han, and Yeong-Min Park. "Selective Tumor-Specific Antigen Delivery to Dendritic Cells Using Mannose-Labeled Poly(d, l-lactide-co-glycolide) Nanoparticles for Cancer Immunotherapy." Journal of Biomedical Nanotechnology 16, no. 2 (February 1, 2020): 201–11. http://dx.doi.org/10.1166/jbn.2020.2883.
Full textSwanson, Anna, Danli Wu, Isere Kuiatse, Hong-Sung Kim, Helen Heslop, Malcolm Brenner, and Patricia Yotnda. "Delivery of tumor-targeted immunotoxin by tumor-specific T cells (155.19)." Journal of Immunology 186, no. 1_Supplement (April 1, 2011): 155.19. http://dx.doi.org/10.4049/jimmunol.186.supp.155.19.
Full textYuba, Eiji, Yoshiki Fukaya, Shin Yanagihara, Nozomi Kasho, and Atsushi Harada. "Development of Mannose-Modified Carboxylated Curdlan-Coated Liposomes for Antigen Presenting Cell Targeted Antigen Delivery." Pharmaceutics 12, no. 8 (August 11, 2020): 754. http://dx.doi.org/10.3390/pharmaceutics12080754.
Full textMurty, Rohan, Abishek Sankaranarayanan, Isabella I. Bowland, Juan Mena-Lapaix, and Mark R. Prausnitz. "Angled Insertion of Microneedles for Targeted Antigen Delivery to the Epidermis." Pharmaceutics 14, no. 2 (February 1, 2022): 347. http://dx.doi.org/10.3390/pharmaceutics14020347.
Full textShaw, Christine A., and Michael N. Starnbach. "Stimulation of CD8+ T Cells following Diphtheria Toxin-Mediated Antigen Delivery into Dendritic Cells." Infection and Immunity 74, no. 2 (February 2006): 1001–8. http://dx.doi.org/10.1128/iai.74.2.1001-1008.2006.
Full textCiccotelli, Jo Erika, Helene Toussaint, Geza Erdos, Cara Carey, Simon Watkins, and Louis Falo. "Intradermal immunization with polyguanine conjugated antigens enables targeted and sustained delivery of protein antigens to dendritic cells in vivo. (APP3P.111)." Journal of Immunology 192, no. 1_Supplement (May 1, 2014): 111.12. http://dx.doi.org/10.4049/jimmunol.192.supp.111.12.
Full textRaiber, Eun-Ang, Calogero Tulone, Yanjing Zhang, Luisa Martinez-Pomares, Emily Steed, Anna M. Sponaas, Jean Langhorne, Mahdad Noursadeghi, Benjamin M. Chain, and Alethea B. Tabor. "Targeted Delivery of Antigen Processing Inhibitors to Antigen Presenting Cells via Mannose Receptors." ACS Chemical Biology 5, no. 5 (April 27, 2010): 461–76. http://dx.doi.org/10.1021/cb100008p.
Full textKNOX, D. P. "Development of vaccines against gastrointestinal nematodes." Parasitology 120, no. 7 (May 2000): 43–61. http://dx.doi.org/10.1017/s0031182099005764.
Full textWoodham, Andrew W., Ross W. Cheloha, Jingjing Ling, Mohammad Rashidian, Stephen C. Kolifrath, Maia Mesyngier, Joao N. Duarte, et al. "Targeted delivery of antigens to CD11b+ cells via nanobodies induces strong antigen-specific T cell and anti-tumor responses." Journal of Immunology 200, no. 1_Supplement (May 1, 2018): 181.6. http://dx.doi.org/10.4049/jimmunol.200.supp.181.6.
Full textHuston, James S., Mei-Sheng Tai, John McCartney, Peter Keck, and Hermann Oppermann. "Antigen recognition and targeted delivery by the single-chain Fv." Cell Biophysics 22, no. 1-3 (January 1993): 189–224. http://dx.doi.org/10.1007/bf03033874.
Full textWang, Max Mu, Mi Ran Choi, Bin Zhang, and Nathan Gianneschi. "A novel polymeric peptide delivery platform and association with targeted co-delivery of antigens and STING agonists with antitumor immune response." Journal of Clinical Oncology 40, no. 16_suppl (June 1, 2022): 2564. http://dx.doi.org/10.1200/jco.2022.40.16_suppl.2564.
Full textWang, Max Mu, Mi Ran Choi, Bin Zhang, and Nathan Gianneschi. "A novel polymeric peptide delivery platform and association with targeted co-delivery of antigens and STING agonists with antitumor immune response." Journal of Clinical Oncology 40, no. 16_suppl (June 1, 2022): 2564. http://dx.doi.org/10.1200/jco.2022.40.16_suppl.2564.
Full textkheirollahpour, Mehdi, Mohsen Mehrabi, Naser Mohammadpour Dounighi, Mohsen Mohammadi, and Alireza Masoudi. "Nanoparticles and Vaccine Development." Pharmaceutical Nanotechnology 8, no. 1 (February 6, 2020): 6–21. http://dx.doi.org/10.2174/2211738507666191024162042.
Full textDahlgren, David, and Hans Lennernäs. "Antibody-Drug Conjugates and Targeted Treatment Strategies for Hepatocellular Carcinoma: A Drug-Delivery Perspective." Molecules 25, no. 12 (June 21, 2020): 2861. http://dx.doi.org/10.3390/molecules25122861.
Full textCampbell, Katrin, Vivienne L. Young, Braeden C. Donaldson, Matthew J. Woodall, Nicholas J. Shields, Greg F. Walker, Vernon K. Ward, and Sarah L. Young. "Delivering Two Tumour Antigens Survivin and Mucin-1 on Virus-Like Particles Enhances Anti-Tumour Immune Responses." Vaccines 9, no. 5 (May 6, 2021): 463. http://dx.doi.org/10.3390/vaccines9050463.
Full textNabi, I. R., A. Le Bivic, D. Fambrough, and E. Rodriguez-Boulan. "An endogenous MDCK lysosomal membrane glycoprotein is targeted basolaterally before delivery to lysosomes." Journal of Cell Biology 115, no. 6 (December 15, 1991): 1573–84. http://dx.doi.org/10.1083/jcb.115.6.1573.
Full textToussaint, Helene, Geza Erdos, and Louis D. Falo, Jr. "Targeted delivery of Poly(dG) conjugated protein antigens to antigen presenting cells results in efficient cross-priming in vivo (78.32)." Journal of Immunology 182, no. 1_Supplement (April 1, 2009): 78.32. http://dx.doi.org/10.4049/jimmunol.182.supp.78.32.
Full textAffandi, Alsya J., Joanna Grabowska, Katarzyna Olesek, Miguel Lopez Venegas, Arnaud Barbaria, Ernesto Rodríguez, Patrick P. G. Mulder, et al. "Selective tumor antigen vaccine delivery to human CD169+antigen-presenting cells using ganglioside-liposomes." Proceedings of the National Academy of Sciences 117, no. 44 (October 16, 2020): 27528–39. http://dx.doi.org/10.1073/pnas.2006186117.
Full textLe Gall, Camille, Anna Cammarata, Lukas de Haas, Iván Ramos-Tomillero, Jorge Cuenca-Escalona, Kayleigh Schouren, Zacharias Wijfjes, et al. "Efficient targeting of NY-ESO-1 tumor antigen to human cDC1s by lymphotactin results in cross-presentation and antigen-specific T cell expansion." Journal for ImmunoTherapy of Cancer 10, no. 4 (April 2022): e004309. http://dx.doi.org/10.1136/jitc-2021-004309.
Full textShrestha, Angita, Jean-Remy Sadeyen, and Munir Iqbal. "Enhancing Protective Efficacy of Poultry Vaccines through Targeted Delivery of Antigens to Antigen-Presenting Cells." Vaccines 6, no. 4 (November 15, 2018): 75. http://dx.doi.org/10.3390/vaccines6040075.
Full textPetzold, Cathleen, Sonja Schallenberg, Joel N. H. Stern, and Karsten Kretschmer. "Targeted Antigen Delivery to DEC-205+Dendritic Cells for Tolerogenic Vaccination." Review of Diabetic Studies 9, no. 4 (2012): 305–18. http://dx.doi.org/10.1900/rds.2012.9.305.
Full textAL Fayez, Nojoud, Elham Rouhollahi, Chun Yat Ong, Jiamin Wu, Anne Nguyen, Roland Böttger, Pieter R. Cullis, Dominik Witzigmann, and Shyh-Dar Li. "Hepatocyte-targeted delivery of imiquimod reduces hepatitis B virus surface antigen." Journal of Controlled Release 350 (October 2022): 630–41. http://dx.doi.org/10.1016/j.jconrel.2022.08.058.
Full textMuraoka, Daisuke, Naohiro Seo, Tae Hayashi, Yoshiro Tahara, Keisuke Fujii, Isao Tawara, Yoshihiro Miyahara, et al. "Antigen delivery targeted to tumor-associated macrophages overcomes tumor immune resistance." Journal of Clinical Investigation 129, no. 3 (February 11, 2019): 1278–94. http://dx.doi.org/10.1172/jci97642.
Full textKouno, Michiyoshi, Norman Schechter, and John R. Stanley. "OI0245 Oral cancer treatment by tumor antigen–targeted drug delivery system." Oral Surgery, Oral Medicine, Oral Pathology and Oral Radiology 117, no. 5 (May 2014): e338-e339. http://dx.doi.org/10.1016/j.oooo.2014.01.042.
Full textChattergoon, Michael A., J. Joseph Kim, Joo-Sung Yang, Tara M. Robinson, Daniel J. Lee, Tzvete Dentchev, Darren M. Wilson, Velpandi Ayyavoo, and David B. Weiner. "Targeted antigen delivery to antigen–presenting cells including dendritic cells by engineered Fas-mediated apoptosis." Nature Biotechnology 18, no. 9 (September 2000): 974–79. http://dx.doi.org/10.1038/79470.
Full textChatterjee, Bithi, Anna Smed-Sörensen, Lillian Cohn, Cécile Chalouni, Richard Vandlen, Byoung-Chul Lee, Jenifer Widger, Tibor Keler, Lélia Delamarre, and Ira Mellman. "Internalization and endosomal degradation of receptor-bound antigens regulate the efficiency of cross presentation by human dendritic cells." Blood 120, no. 10 (September 6, 2012): 2011–20. http://dx.doi.org/10.1182/blood-2012-01-402370.
Full textLi, Zhenhua, Kai Dong, Yan Zhang, Enguo Ju, Zhaowei Chen, Jinsong Ren, and Xiaogang Qu. "Biomimetic nanoassembly for targeted antigen delivery and enhanced Th1-type immune response." Chemical Communications 51, no. 88 (2015): 15975–78. http://dx.doi.org/10.1039/c5cc06794d.
Full textGallovic, Matthew D., Douglas G. Montjoy, Michael A. Collier, Clement Do, Barbara E. Wyslouzil, Eric M. Bachelder, and Kristy M. Ainslie. "Chemically modified inulin microparticles serving dual function as a protein antigen delivery vehicle and immunostimulatory adjuvant." Biomaterials Science 4, no. 3 (2016): 483–93. http://dx.doi.org/10.1039/c5bm00451a.
Full textAssani, Kaivon, Amy Neidhard-Doll, and Tarun Goswami. "Mechanical properties of nanoparticles in the drug delivery kinetics." Journal of Pharmaceutical and Biopharmaceutical Research 4, no. 1 (2022): 248–55. http://dx.doi.org/10.25082/jpbr.2022.01.002.
Full textCohn, Lillian, Bithi Chatterjee, Filipp Esselborn, Anna Smed-Sörensen, Norihiro Nakamura, Cécile Chalouni, Byoung-Chul Lee, et al. "Antigen delivery to early endosomes eliminates the superiority of human blood BDCA3+ dendritic cells at cross presentation." Journal of Experimental Medicine 210, no. 5 (April 8, 2013): 1049–63. http://dx.doi.org/10.1084/jem.20121251.
Full textIwamura, Chie, Charles Benck, William Coley, Yi Liu, Yongge Zhao, Juan Antonio Quiel Esposito, and Kristin V. Tarbell. "Autoreactive T cells display altered CD25 expression that changes responses to low dose IL-2 and antigen delivery." Journal of Immunology 198, no. 1_Supplement (May 1, 2017): 127.21. http://dx.doi.org/10.4049/jimmunol.198.supp.127.21.
Full textSaeed, Mesha, Sara Zalba, Ann Seynhaeve, Reno Debets, and Timo L. M. ten Hagen. "Liposomes targeted to MHC-restricted antigen improve drug delivery and antimelanoma response." International Journal of Nanomedicine Volume 14 (March 2019): 2069–89. http://dx.doi.org/10.2147/ijn.s190736.
Full textShakya, Akhilesh Kumar, and Kutty Selva Nandakumar. "Antigen-Specific Tolerization and Targeted Delivery as Therapeutic Strategies for Autoimmune Diseases." Trends in Biotechnology 36, no. 7 (July 2018): 686–99. http://dx.doi.org/10.1016/j.tibtech.2018.02.008.
Full textBaert, Kim, Bruno G. de Geest, Riet de Rycke, André B. da Fonseca Antunes, Henri de Greve, Eric Cox, and Bert Devriendt. "β-glucan microparticles targeted to epithelial APN as oral antigen delivery system." Journal of Controlled Release 220 (December 2015): 149–59. http://dx.doi.org/10.1016/j.jconrel.2015.10.025.
Full textHawiger, Daniel, Kayo Inaba, Yair Dorsett, Ming Guo, Karsten Mahnke, Miguel Rivera, Jeffrey V. Ravetch, Ralph M. Steinman, and Michel C. Nussenzweig. "Dendritic Cells Induce Peripheral T Cell Unresponsiveness under Steady State Conditions in Vivo." Journal of Experimental Medicine 194, no. 6 (September 17, 2001): 769–80. http://dx.doi.org/10.1084/jem.194.6.769.
Full textAlarcon, Neftali Ortega, Maddy Jaramillo, Heidi M. Mansour, and Bo Sun. "Therapeutic Cancer Vaccines—Antigen Discovery and Adjuvant Delivery Platforms." Pharmaceutics 14, no. 7 (July 11, 2022): 1448. http://dx.doi.org/10.3390/pharmaceutics14071448.
Full textJi, Xiaoting, Haoyuan Lv, Xinxin Sun, and Caifeng Ding. "Green-emitting carbon dot loaded silica nanoparticles coated with DNA-cross-linked hydrogels for sensitive carcinoembryonic antigen detection and effective targeted cancer therapy." Chemical Communications 55, no. 100 (2019): 15101–4. http://dx.doi.org/10.1039/c9cc07831b.
Full textAmato, Robert J., and Mika Stepankiw. "Clinical Efficacy of TroVax in the Treatment of Progressive Castration-resistant Prostate Cancer." Clinical Medicine Insights: Oncology 6 (January 2012): CMO.S7654. http://dx.doi.org/10.4137/cmo.s7654.
Full textFeng, Haibo, Yangyang Feng, Lang Lin, Daiyan Wu, Qianqian Liu, Hangyu Li, Xinnan Zhang, et al. "Mannose Receptor-Mediated Carbon Nanotubes as an Antigen Delivery System to Enhance Immune Response Both In Vitro and In Vivo." International Journal of Molecular Sciences 23, no. 8 (April 11, 2022): 4239. http://dx.doi.org/10.3390/ijms23084239.
Full textFeng, Haibo, Xiaonong Yang, Linzi Zhang, Qianqian Liu, Yangyang Feng, Daiyan Wu, Yunjie Liu, and Jie Yang. "Mannose-Modified Chitosan Poly(lactic-co-glycolic acid) Microspheres Act as a Mannose Receptor-Mediated Delivery System Enhancing the Immune Response." Polymers 13, no. 13 (July 3, 2021): 2208. http://dx.doi.org/10.3390/polym13132208.
Full textGardner, Thomas J., Christopher M. Bourne, Megan M. Dacek, Keifer Kurtz, Manish Malviya, Leila Peraro, Pedro C. Silberman, et al. "Targeted Cellular Micropharmacies: Cells Engineered for Localized Drug Delivery." Cancers 12, no. 8 (August 5, 2020): 2175. http://dx.doi.org/10.3390/cancers12082175.
Full textDobrovolskaia, Marina A. "Nucleic Acid Nanoparticles at a Crossroads of Vaccines and Immunotherapies." Molecules 24, no. 24 (December 17, 2019): 4620. http://dx.doi.org/10.3390/molecules24244620.
Full textSalaheldin, Taher A., Dhruba J. Bharali, and Shaker A. Mousa. "Functionalized nano-targeted moieties in management of prostate cancer." Future Oncology 16, no. 13 (May 2020): 869–83. http://dx.doi.org/10.2217/fon-2019-0635.
Full textArpit Rajaram Suralkar, Chaitanya Shahaji Khedkar, Nidhi R Zanwar, Chanchal C Chandak, and Shital J Gandhi. "Liposomes as a novel drug delivery system." GSC Biological and Pharmaceutical Sciences 20, no. 3 (September 30, 2022): 336–43. http://dx.doi.org/10.30574/gscbps.2022.20.3.0372.
Full textHossain, Dewan Md Sakib, Cedric Dos Santos, Qifang Zhang, Anna Kozlowska, Hongjun Liu, Chan Gao, Dayson Moreira, et al. "Leukemia cell–targeted STAT3 silencing and TLR9 triggering generate systemic antitumor immunity." Blood 123, no. 1 (January 2, 2014): 15–25. http://dx.doi.org/10.1182/blood-2013-07-517987.
Full textSchnurr, Max, Qiyuan Chen, Amanda Shin, Weisan Chen, Tracey Toy, Corinna Jenderek, Simon Green, et al. "Tumor antigen processing and presentation depend critically on dendritic cell type and the mode of antigen delivery." Blood 105, no. 6 (March 15, 2005): 2465–72. http://dx.doi.org/10.1182/blood-2004-08-3105.
Full textMorse, M., R. Chapman, T. Clay, T. Osada, A. Hobeika, J. Green, T. Davis, and T. Keler. "Antigen presenting cell (APC)-targeted hCGβ vaccine for cancer therapy." Journal of Clinical Oncology 25, no. 18_suppl (June 20, 2007): 3013. http://dx.doi.org/10.1200/jco.2007.25.18_suppl.3013.
Full text